Kineta, Inc. (KA)

$0.66 2.81% $0.02 Healthcare

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.

$8.08M

Dr. Shawn P. Iadonato Ph.D.

11.00

Seattle, WA

Feb 11, 2016

-0.40

$-1.64

0.22

0.25

-2,173.27%

-0.45

-0.02

-1.27

10.57

0.22

-735.14%

-1,066.87%

Similar stocks (16)

XOMA Corporation

XOMAO

$25.31 0.44%
Uptrend

PepGen Inc.

PEPG

$8.83 -0.34%
Downtrend

Rezolute, Inc.

RZLT

$4.35 -0.46%
Neutral

Candel Therapeutics, Inc.

CADL

$6.14 -2.69%
Uptrend

DiaMedica Therapeutics Inc.

DMAC

$4.03 4.68%
Uptrend

AlloVir, Inc.

ALVR

$0.76 0.37%
Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$1.80 2.27%
Downtrend

Dyadic International, Inc.

DYAI

$1.26 -0.79%
Downtrend

Tempest Therapeutics, Inc.

TPST

$1.24 -0.80%
Downtrend

MiNK Therapeutics, Inc.

INKT

$0.79 -0.22%
Downtrend

Lumos Pharma, Inc.

LUMO

$3.80 -0.26%
Neutral

AN2 Therapeutics, Inc.

ANTX

$1.02 -0.97%
Downtrend

Forte Biosciences, Inc.

FBRX

$7.61 -1.55%
Downtrend

Kintara Therapeutics, Inc.

KTRA

$0.17 1.76%
Downtrend

Silo Pharma, Inc.

SILO

$1.20 0.67%
Downtrend

Protagenic Therapeutics, Inc.

PTIX

$0.76 7.47%
Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$129.08 -1.69%
Neutral

Vanguard Extended Market Index Fund

VXF

0%

$170.15 -1.70%
Neutral